Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(33 sites)
Austria
Medical University of Innsbruck, Innsbruck Kepler University Hospital - Neuromed campus, Linz Medical University of Vienna, Vienna Belgium
Universitair Ziekenhuis Brussel, Brussels Ghent University Hospital, Ghent U.Z. Leuven - Campus Gasthuisberg, Leuven Czechia
Masaryk Memorial Cancer Institute, Brno France
Universitary hospital Bordeaux France, Bordeaux CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon Marseille APHM, Marseille Assistance Publique Hopitaux de Paris APHP - Sorbonne, Paris Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse Germany
Universitaskliniken Bonn, Bonn University Hospital Frankfurt -Senckenberg Institute of Neurooncology, Frankfurt NNeurology department heidelberg, Heidelberg Mannheim University Hospital, Mannheim Universitaetsklinikum Regensburg, Regensburg Italy
Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche - AUSL di Bologna, Bologna Veneto Institute of Oncology, Padova Sapienza University, Roma AOU Citta della Salute e della Scienza di Torino, Torino Netherlands
Amsterdam UMC location VUMC, Amsterdam Academisch Ziekenhuis Maastricht, Maastricht Spain
Hospital de Sant Pau i La Santa Creu, Barcelona Vall de Hebron Hospital, Barcelona Hospital Universitario 12 de Octubre, Madrid Switzerland
University Hospital Basel, Basel University Hospital Zurich, Zurich United Kingdom
Queen Elizabeth Hospital Birmingham, Birmingham The Christie NHS Foundation Trust, Manchester Clatterbridge Cancer Centre, Metropolitan Borough of Wirral Royal Marsden Hospital, Surrey Quays